FEMSelect Company

FEMSelect is making a lasting impact on women's health by delivering an innovative technology platform. FEMSelect (formerly POP Medical Solutions) has developed a minimally invasive, meshless, dissectionless approach to pelvic organ prolapse repair. The device has been cleared by the FDA and CE Marked and is available commercially.
Industry: Pelvic & Uterine Healthcare
Headquarters: Modi'in, HaMerkaz, Israel
Founded Date: 01-01-2012
Employees Number: 1-10
Funding Status: Early Stage Venture
Investors Number: 9
Total Funding: $12,795,000
Last Funding Date: 2022-10-19
Last Funding Type: Series B

Visit Website
Register and Claim Ownership